(Q35542640)

8 August 2017

1 reference

title

Probiotics for the treatment of postoperative complications following intestinal surgery (English)

1 reference

8 August 2017

0 references

Fernando Rizzello

3

0 references

Massimo Campieri

object named as

Massimo Campieri

series ordinal

6

0 references

Paolo Gionchetti

object named as

Paolo Gionchetti

series ordinal

1

0 references

Gilberto Poggioli

series ordinal

5

object named as

Gilberto Poggioli

1 reference

8 August 2017

2

Cristina Amadini

1 reference

8 August 2017

Alessandro Venturi

4

1 reference

8 August 2017

publication date

1 October 2003

1 reference

Best Practice and Research: Clinical Gastroenterology

8 August 2017

published in

1 reference

8 August 2017

volume

17

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

821-831

1 reference

Enteric Microflora in IBD: Pathogens or Commensals?

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Probiotics--role in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Proctocolectomy without ileostomy for ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Restorative proctocolectomy with ileal reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

1 reference

7 January 2021

Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Inflammation in ileal reservoirs: 'pouchitis'.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Endoscopic assessment of acute inflammation of the ileal reservoir after restorative ileo-anal anastomosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Pouchitis: result of microbial imbalance?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Factors determining recurrence following surgery for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Analysis of clinical course of postoperative recurrence in Crohn's Disease of distal ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Role of the faecal stream in the maintenance of Crohn's colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900071-4

7 January 2021

10.1016/S1521-6918(03)00071-4

Identifiers

DOI

1 reference

8 August 2017

1 reference